1. Extracellular vesicles  produced by bone marrow mesenchymal stem cells overexpressing programmed death‐ligand 1 ameliorate dextran sodium sulfate‐induced ulcerative colitis in rats by regulating Th17/Treg cell balance through PTEN/PI3K/AKT/mTOR axis
   Hongxia He et al, 2022, Journal of Gastroenterology and Hepatology CrossRef
2. Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation, Oxidative Stress and Apoptosis
   Jia Yang et al, 2015, PLOS ONE CrossRef
3. BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1
   Fei Gao et al, 2022, Biotechnology Letters CrossRef
4. Immortalized Canine Adipose-Derived Mesenchymal Stem Cells Maintain the Immunomodulatory Capacity of the Original Primary Cells
   Yuyo Yasumura et al, 2023, International Journal of Molecular Sciences CrossRef
5. The role of mesenchymal stem cells in attenuating inflammatory bowel disease through ubiquitination
   Hong Xi Liao et al, 2024, Frontiers in Immunology CrossRef
6. The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis
   Ainsley M. Robinson et al, 2017, Stem Cell Research & Therapy CrossRef
7. Systematic Exposition of Mesenchymal Stem Cell for Inflammatory Bowel Disease and Its Associated Colorectal Cancer
   Jingjing Kang et al, 2018, BioMed Research International CrossRef
8. Differential Analysis of Serum Principal Components Treated with Compound Sophora Decoction and Related Compounds Based on High‐Resolution Mass Spectrometry (HRMS)
   Wanjin Sun et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
9. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials
   Li-Tzu Wang et al, 2016, Journal of Biomedical Science CrossRef